These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9329180)

  • 21. Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties.
    Desos P; Lepagnol JM; Morain P; Lestage P; Cordi AA
    J Med Chem; 1996 Jan; 39(1):197-206. PubMed ID: 8568808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular pharmacology of the AMPA agonist, (S)-2-amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid [(S)-APPA] and the AMPA antagonist, (R)-APPA.
    Ebert B; Madsen U; Lund TM; Lenz SM; Krogsgaard-Larsen P
    Neurochem Int; 1994 Jun; 24(6):507-15. PubMed ID: 7526921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity.
    Ornstein PL; Arnold MB; Allen NK; Bleisch T; Borromeo PS; Lugar CW; Leander JD; Lodge D; Schoepp DD
    J Med Chem; 1996 May; 39(11):2232-44. PubMed ID: 8667366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid.
    Bräuner-Osborne H; Sløk FA; Skjaerbaek N; Ebert B; Sekiyama N; Nakanishi S; Krogsgaard-Larsen P
    J Med Chem; 1996 Aug; 39(16):3188-94. PubMed ID: 8759641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AMPA receptor agonists: synthesis, protolytic properties, and pharmacology of 3-isothiazolol bioisosteres of glutamic acid.
    Matzen L; Engesgaard A; Ebert B; Didriksen M; Frølund B; Krogsgaard-Larsen P; Jaroszewski JW
    J Med Chem; 1997 Feb; 40(4):520-7. PubMed ID: 9046343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-(N-oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: novel, systemically active and broad spectrum antagonists for NMDA/glycine, AMPA, and kainate receptors.
    Cai SX; Huang JC; Espitia SA; Tran M; Ilyin VI; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Oct; 40(22):3679-86. PubMed ID: 9357535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-alpha]quinoxalinone and related compounds: synthesis and structure-activity relationships for the AMPA-type non-NMDA receptor.
    Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
    J Med Chem; 1997 Jun; 40(13):2053-63. PubMed ID: 9207947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
    Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
    J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aryl and cycloalkyl analogues of AMPA: synthetic, pharmacological and stereochemical aspects.
    Skjaerbaek N; Brehm L; Johansen TN; Hansen LM; Nielsen B; Ebert B; Søby KK; Stensbøl TB; Falch E; Krogsgaard-Larsen P
    Bioorg Med Chem; 1998 Jan; 6(1):119-31. PubMed ID: 9502111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and structure-activity studies on acidic amino acids and related diacids as NMDA receptor ligands.
    Johansen TN; Frydenvang K; Ebert B; Krogsgaard-Larsen P; Madsen U
    J Med Chem; 1994 Sep; 37(20):3252-62. PubMed ID: 7523673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel AMPA receptor antagonists: synthesis and structure-activity relationships of 1-hydroxy-7-(1H-imidazol-1-yl)-6-nitro-2,3(1H,4H)- quinoxalinedione and related compounds.
    Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
    J Med Chem; 1996 Sep; 39(20):3971-9. PubMed ID: 8831762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of in vivo effects of AMPA and NMDA receptor ligands using drug discrimination methods and convulsant/anticonvulsant activity.
    Arnt J; Sánchez C; Lenz SM; Madsen U; Krogsgaard-Larsen P
    Eur J Pharmacol; 1995 Oct; 285(3):289-97. PubMed ID: 8575516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and pharmacology of highly selective carboxy and phosphono isoxazole amino acid AMPA receptor antagonists.
    Madsen U; Bang-Andersen B; Brehm L; Christensen IT; Ebert B; Kristoffersen IT; Lang Y; Krogsgaard-Larsen P
    J Med Chem; 1996 Apr; 39(8):1682-91. PubMed ID: 8648608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AMPA and NMDA receptor regulation of firing activity in 5-HT neurons of the dorsal and median raphe nuclei.
    Gartside SE; Cole AJ; Williams AP; McQuade R; Judge SJ
    Eur J Neurosci; 2007 May; 25(10):3001-8. PubMed ID: 17509083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (S)-homo-AMPA, a specific agonist at the mGlu6 subtype of metabotropic glutamic acid receptors.
    Ahmadian H; Nielsen B; Bräuner-Osborne H; Johansen TN; Stensbøl TB; Sløk FA; Sekiyama N; Nakanishi S; Krogsgaard-Larsen P; Madsen U
    J Med Chem; 1997 Oct; 40(22):3700-5. PubMed ID: 9357538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ionotropic excitatory amino acid receptor ligands. Synthesis and pharmacology of a new amino acid AMPA antagonist.
    Madsen U; Sløk FA; Stensbøl TB; Bräuner-Osborne H; Lützhøft HH; Poulsen MV; Eriksen L; Krogsgaard-Larsen P
    Eur J Med Chem; 2000 Jan; 35(1):69-76. PubMed ID: 10733604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell death.
    Vegh MG; Kovács AD; Kovács G; Szabó G; Tihanyi K; Hársing LG; Lévay G
    Neurochem Int; 2007 Feb; 50(3):555-63. PubMed ID: 17147974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GABAB antagonists: resolution, absolute stereochemistry, and pharmacology of (R)- and (S)-phaclofen.
    Frydenvang K; Hansen JJ; Krogsgaard-Larsen P; Mitrovic A; Tran H; Drew CA; Johnston GA
    Chirality; 1994; 6(7):583-9. PubMed ID: 7986672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The respective N-hydroxypyrazole analogues of the classical glutamate receptor ligands ibotenic acid and (RS)-2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid.
    Clausen RP; Hansen KB; Calí P; Nielsen B; Greenwood JR; Begtrup M; Egebjerg J; Bräuner-Osborne H
    Eur J Pharmacol; 2004 Sep; 499(1-2):35-44. PubMed ID: 15363949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and pharmacology of the baclofen homologues 5-amino-4-(4-chlorophenyl)pentanoic acid and the R- and S-enantiomers of 5-amino-3-(4-chlorophenyl)pentanoic acid.
    Karla R; Ebert B; Thorkildsen C; Herdeis C; Johansen TN; Nielsen B; Krogsgaard-Larsen P
    J Med Chem; 1999 Jun; 42(11):2053-9. PubMed ID: 10354414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.